These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22123434

  • 1. Resection of focally progressive gastrointestinal stromal tumours resistant to imatinib therapy.
    Tse GH, Wong EH, O'Dwyer PJ.
    Surgeon; 2012 Dec; 10(6):309-13. PubMed ID: 22123434
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, Hohenberger P.
    Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
    [Abstract] [Full Text] [Related]

  • 3. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [Abstract] [Full Text] [Related]

  • 4. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH.
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [Abstract] [Full Text] [Related]

  • 5. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S, Eldweny H, Péchoux CL, Vanel D, Terrier P, Cavalcanti A, Robert C, Lassau N, Cesne AL.
    Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M, Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A.
    Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
    [Abstract] [Full Text] [Related]

  • 7. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S.
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [Abstract] [Full Text] [Related]

  • 8. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
    Wilkinson MJ, Fitzgerald JE, Strauss DC, Hayes AJ, Thomas JM, Messiou C, Fisher C, Benson C, Tekkis PP, Judson I.
    Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
    [Abstract] [Full Text] [Related]

  • 9. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.
    Ruka W, Rutkowski P, Szawłowski A, Nowecki Z, Debiec-Rychter M, Grzesiakowska U, Dziewirski W, Siedlecki JA, Michej W.
    Eur J Surg Oncol; 2009 Jan; 35(1):87-91. PubMed ID: 18289826
    [Abstract] [Full Text] [Related]

  • 10. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC, Belgaumkar A, Lorenzi B, Mudan S.
    ANZ J Surg; 2014 Dec; 84(12):937-42. PubMed ID: 25444423
    [Abstract] [Full Text] [Related]

  • 11. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC, Belgaumkar AP, Lorenzi B, Mudan S.
    ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808
    [Abstract] [Full Text] [Related]

  • 12. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.
    An HJ, Ryu MH, Ryoo BY, Sohn BS, Kim KH, Oh ST, Yu CS, Yook JH, Kim BS, Kang YK.
    Ann Surg Oncol; 2013 Dec; 20(13):4212-8. PubMed ID: 24052319
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis analysis of 216 cases of gastrointestinal stromal tumor].
    Liu LC, Xu WT.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):255-8. PubMed ID: 22454172
    [Abstract] [Full Text] [Related]

  • 14. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 15. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).
    Sym SJ, Ryu MH, Lee JL, Chang HM, Kim TW, Kim HC, Kim KH, Yook JH, Kim BS, Kang YK.
    J Surg Oncol; 2008 Jul 01; 98(1):27-33. PubMed ID: 18452195
    [Abstract] [Full Text] [Related]

  • 16. Surgery for gastrointestinal stromal tumour in the post-imatinib era.
    Neuhaus SJ, Clark MA, Hayes AJ, Thomas JM, Judson I.
    ANZ J Surg; 2005 Mar 01; 75(3):165-72. PubMed ID: 15777399
    [Abstract] [Full Text] [Related]

  • 17. Neoodjuvant imatinib mesylate for advanced primary and metastactic/recurrent gastro-intestinal stromal tumour (GIST).
    Das D, Ganguly S, Deb AR, Aich RK.
    J Indian Med Assoc; 2013 Jan 01; 111(1):21-3. PubMed ID: 24000503
    [Abstract] [Full Text] [Related]

  • 18. [A case of recurrent gastrointestinal stromal tumor progressing after interruption of long-term imatinib therapy].
    Nakatsuka R, Takahashi T, Miyazaki Y, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y.
    Gan To Kagaku Ryoho; 2014 Nov 01; 41(12):2478-80. PubMed ID: 25731563
    [Abstract] [Full Text] [Related]

  • 19. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
    Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F.
    Ann Surg Oncol; 2013 Sep 01; 20(9):2937-43. PubMed ID: 23760587
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S, Nakata K, Kajiura S, Ando T, Hosokawa A, Sugiyama T.
    Digestion; 2013 Sep 01; 87(1):47-52. PubMed ID: 23343969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.